Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Vaccines

  Free Subscription


08.04.2019

1 Ann N Y Acad Sci
1 Arch Virol
4 BMJ
1 Clin Infect Dis
2 Infect Immun
1 J Infect Dis
1 J Virol
2 Lancet Infect Dis
7 PLoS One
13 Vaccine
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann N Y Acad Sci

  1. ZAIDI N, Quezada SA, Kuroiwa JMY, Zhang L, et al
    Anti-CTLA-4 synergizes with dendritic cell-targeted vaccine to promote IL-3-dependent CD4(+) effector T cell infiltration into murine pancreatic tumors.
    Ann N Y Acad Sci. 2019 Apr 4. doi: 10.1111/nyas.14049.
    PubMed     Text format     Abstract available


    Arch Virol

  2. KONONOV A, Byadovskaya O, Kononova S, Yashin R, et al
    Detection of vaccine-like strains of lumpy skin disease virus in outbreaks in Russia in 2017.
    Arch Virol. 2019 Apr 4. pii: 10.1007/s00705-019-04229.
    PubMed     Text format     Abstract available


    BMJ

  3. BROTHERTON JML
    The remarkable impact of bivalent HPV vaccine in Scotland.
    BMJ. 2019;365:l1375.
    PubMed     Text format    

  4. PALMER T, Wallace L, Pollock KG, Cuschieri K, et al
    Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study.
    BMJ. 2019;365:l1161.
    PubMed     Text format     Abstract available

  5. LE P, Rothberg M
    Herpes zoster infection.
    BMJ. 2019;364:k5095.
    PubMed     Text format    

  6. PARRY CM, Ribeiro I, Walia K, Rupali P, et al
    Multidrug resistant enteric fever in South Asia: unmet medical needs and opportunities.
    BMJ. 2019;364:k5322.
    PubMed     Text format    


    Clin Infect Dis

  7. MOSCICKI AB, Karalius B, Tassiopoulos K, Yao TJ, et al
    Human Papillomavirus Antibody Levels and Quadrivalent Vaccine Clinical Effectiveness in Perinatally Human Immunodeficiency Virus-infected and Exposed, Uninfected Youth.
    Clin Infect Dis. 2019 Feb 21. pii: 5423927. doi: 10.1093/cid/ciy1040.
    PubMed     Text format     Abstract available


    Infect Immun

  8. KHALAF OH, Chaki SP, Garcia-Gonzalez DG, Ficht TA, et al
    NOD-scid IL2rgamma(null) Mouse Model is suitable to Study Osteoarticular Brucellosis and Vaccine Safety.
    Infect Immun. 2019 Apr 1. pii: IAI.00901-18. doi: 10.1128/IAI.00901.
    PubMed     Text format     Abstract available

  9. YOUNG PG, Raynes JM, Loh JM, Proft T, et al
    Group A Streptococcus T-antigens have a highly conserved structure concealed under a heterogeneous surface that has implications for vaccine design.
    Infect Immun. 2019 Apr 1. pii: IAI.00205-19. doi: 10.1128/IAI.00205.
    PubMed     Text format     Abstract available


    J Infect Dis

  10. CHEN C, van Schaik EJ, Gregory AE, Vigil A, et al
    Chemokine Receptor 7 is Essential for Coxiella burnetii Whole-Cell Vaccine Induced Cellular Immunity but Dispensable for Vaccine Mediated Protective Immunity.
    J Infect Dis. 2019 Apr 2. pii: 5425888. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Virol

  11. SUN W, Kirkpatrick E, Ermler M, Nachbagauer R, et al
    Development of Influenza B Universal Vaccine Candidates using the "Mosaic" Hemagglutinin Approach.
    J Virol. 2019 Apr 3. pii: JVI.00333-19. doi: 10.1128/JVI.00333.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  12. BARUG D, Pronk I, van Houten MA, Versteegh FGA, et al
    Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial.
    Lancet Infect Dis. 2019;19:392-401.
    PubMed     Text format     Abstract available

  13. ELLWANGER JH, Chies JAB
    Host genetic factors can impact vaccine immunogenicity and effectiveness.
    Lancet Infect Dis. 2019;19:359-360.
    PubMed     Text format    


    PLoS One

  14. MATHEW E, Zhu H, Connelly SM, Sullivan MA, et al
    Display of the HIV envelope protein at the yeast cell surface for immunogen development.
    PLoS One. 2018;13:e0205756.
    PubMed     Text format     Abstract available

  15. ERDEM G, Singh AK, Brusnahan AJ, Moore AN, et al
    Pneumococcal colonization among tracheostomy tube dependent children.
    PLoS One. 2018;13:e0206305.
    PubMed     Text format     Abstract available

  16. ADAMO G, Sturabotti G, Baccolini V, de Soccio P, et al
    Regional reports for the subnational monitoring of measles elimination in Italy and the identification of local barriers to the attainment of the elimination goal.
    PLoS One. 2018;13:e0205147.
    PubMed     Text format     Abstract available

  17. VUPPUTURI S, Rubenstein KB, Derus AJ, Loftus BC, et al
    Factors contributing to racial disparities in influenza vaccinations.
    PLoS One. 2019;14:e0213972.
    PubMed     Text format     Abstract available

  18. MAENETJE P, Lindan C, Makkan H, Chetty-Makkan CM, et al
    HIV incidence and predictors of inconsistent condom use among adult men enrolled into an HIV vaccine preparedness study, Rustenburg, South Africa.
    PLoS One. 2019;14:e0214786.
    PubMed     Text format     Abstract available

  19. WIBABARA Y, Banura C, Kalyango J, Karamagi C, et al
    Hepatitis B vaccination status and associated factors among undergraduate students of Makerere University College of Health Sciences.
    PLoS One. 2019;14:e0214732.
    PubMed     Text format     Abstract available

  20. JUDD A, Foster C, Thompson LC, Sturgeon K, et al
    Sexual health of young people with perinatal HIV and HIV negative young people in England.
    PLoS One. 2018;13:e0205597.
    PubMed     Text format     Abstract available


    Vaccine

  21. OSTER NV, Williams EC, Unger JM, Newcomb PA, et al
    Sociodemographic, clinical and birth hospitalization characteristics and infant Hepatitis B vaccination in Washington State.
    Vaccine. 2019 Mar 28. pii: S0264-410X(19)30384.
    PubMed     Text format     Abstract available

  22. FERNANDES EG, Sato APS, Vaz-de-Lima LRA, Rodrigues M, et al
    The effectiveness of maternal pertussis vaccination in protecting newborn infants in Brazil: A case-control study.
    Vaccine. 2019 Apr 1. pii: S0264-410X(19)30383.
    PubMed     Text format     Abstract available

  23. MENSAH K, Heraud JM, Takahashi S, Winter AK, et al
    Seasonal gaps in measles vaccination coverage in Madagascar.
    Vaccine. 2019 Mar 30. pii: S0264-410X(19)30276.
    PubMed     Text format     Abstract available

  24. PINTO LA, Wilkin TJ, Kemp TJ, Abrahamsen M, et al
    Oral and systemic HPV antibody kinetics post-vaccination among HIV-positive and HIV-negative men.
    Vaccine. 2019 Mar 30. pii: S0264-410X(19)30356.
    PubMed     Text format     Abstract available

  25. LUYTEN J, Bruyneel L, van Hoek AJ
    Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrument.
    Vaccine. 2019 Mar 30. pii: S0264-410X(19)30375.
    PubMed     Text format     Abstract available

  26. LOPEZ-FAUQUED M, Campora L, Delannois F, El Idrissi M, et al
    Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials.
    Vaccine. 2019 Mar 29. pii: S0264-410X(19)30377.
    PubMed     Text format     Abstract available

  27. SAWLWIN DC, Graves Jones A, Albano FR
    Modification of the vaccine manufacturing process improves the pyrogenicity profile of inactivated influenza vaccines in young children.
    Vaccine. 2019 Mar 29. pii: S0264-410X(19)30390.
    PubMed     Text format     Abstract available

  28. SARKAR S, Piepenbrink MS, Basu M, Thakar J, et al
    IL-33 enhances the kinetics and quality of the antibody response to a DNA and protein-based HIV-1 Env vaccine.
    Vaccine. 2019 Mar 26. pii: S0264-410X(19)30378.
    PubMed     Text format     Abstract available

  29. GODI A, Panwar K, Haque M, Cocuzza CE, et al
    Durability of the neutralizing antibody response to vaccine and non-vaccine HPV types 7 years following immunization with either Cervarix(R) or Gardasil(R) vaccine.
    Vaccine. 2019 Mar 27. pii: S0264-410X(19)30386.
    PubMed     Text format     Abstract available

  30. ARNOLD LD, Luong L, Rebmann T, Chang JJ, et al
    Racial disparities in U.S. maternal influenza vaccine uptake: Results from analysis of Pregnancy Risk Assessment Monitoring System (PRAMS) data, 2012-2015.
    Vaccine. 2019 Mar 27. pii: S0264-410X(19)30208.
    PubMed     Text format     Abstract available

  31. POELLABAUER E, Angermayr R, Behre U, Zhang P, et al
    Seropersistence and booster response following vaccination with FSME-IMMUN in children, adolescents, and young adults.
    Vaccine. 2019 Mar 27. pii: S0264-410X(19)30354.
    PubMed     Text format     Abstract available

  32. XIN H, Glee P, Adams A, Mohiuddin F, et al
    Design of a mimotope-peptide based double epitope vaccine against disseminated candidiasis.
    Vaccine. 2019 Mar 28. pii: S0264-410X(19)30407.
    PubMed     Text format     Abstract available

  33. CASHMAN P, Moberley S, Chee K, Stephenson J, et al
    Participant centred safety surveillance of health care workers receiving influenza vaccination.
    Vaccine. 2019 Mar 28. pii: S0264-410X(19)30320.
    PubMed     Text format     Abstract available


    Virology

  34. ITO H, Kanbe A, Hara A, Ishikawa T, et al
    Induction of humoral and cellular immune response to HBV vaccine can be up-regulated by STING ligand.
    Virology. 2019;531:233-239.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: